Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00297453 · ClinicalTrials.gov registry record · Phase 3
Smoking Treatment in HIV Clinical Care Settings
A Phase 3 study of Nicotine Dependence, sponsored by University of California, San Francisco.
- Completed
- Registry status
- Phase 3
- Development phase
- 207
- Enrollment target
- 1
- Study location
NCT00297453: Completed Phase 3 study of Nicotine Dependence, sponsored by University of California, San Francisco.
NCT00297453 is a Phase 3 study of Nicotine Dependence that has completed, run by University of California, San Francisco. The registered enrollment target is 207 participants, above the 184-participant average among 67 other Nicotine Dependence trials with a reported enrollment target (13% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00297453, a Phase 3 study of Nicotine Dependence, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 207 participants
- Enrollment target
- 1
- Study location
Study Summary
The study is designed to evaluate and compare the efficacy and cost effectiveness of 3 smoking cessation treatments with HIV-positive cigarette smokers. The treatments include face-to-face individual counseling, a computer-Internet-based self-help treatment and a self-help manual treatment.
Conditions Studied
Interventions
- BEHAVIORAL Individual Counseling
- BEHAVIORAL Internet-based smoking treatment
- BEHAVIORAL self-help
Study Locations (1)
California
- University of California, San Francisco - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 207 participants |
| Start Date | 2006-01 |
| Est. Completion | 2011-01 |
| Phase | Phase 3 |
What the finished NCT00297453 record still lists
NCT00297453 is an interventional study that assigns participants to a tested intervention. The registered 207 participants enrollment target is mid-sized for trials with a published cap, above the 184-participant average among 67 other Nicotine Dependence trials with a reported enrollment target (13% higher).
The record links to 1 condition, with Nicotine Dependence appearing as the primary indexed condition, and to 3 interventions - of which Individual Counseling is the first listed.
NCT00297453 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT00297453 about?
NCT00297453 is a clinical study titled "Smoking Treatment in HIV Clinical Care Settings". The study is designed to evaluate and compare the efficacy and cost effectiveness of 3 smoking cessation treatments with HIV-positive cigarette smokers. The treatments include face-to-face individual counseling, a computer-Internet-based self-help treatment and a self-help manual treatment.
What is the current status of trial NCT00297453?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 207 participants. The study started on 2006-01. Estimated completion is 2011-01.
What conditions does trial NCT00297453 study?
This clinical trial studies the following conditions: Nicotine Dependence.
What interventions are being tested in trial NCT00297453?
The interventions under investigation include: Individual Counseling (BEHAVIORAL), Internet-based smoking treatment (BEHAVIORAL), self-help (BEHAVIORAL).
Who is sponsoring clinical trial NCT00297453?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00297453 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Nicotine Dependence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00297453's enrollment target sits among peer trials
207 17th of 67 higher than 51 of 67 other Nicotine Dependence trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Nicotine Dependence trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Optimizing Tobacco Use Treatment for PLWHA
RECRUITING · Phase 3
-
Community-based Smoking Cessation Treatment for Adults With High Stress Sensitivity.
RECRUITING · Phase 3
-
Bupropion Treatment for Youth Smoking Cessation
COMPLETED · Phase 3
-
Pharmacokinetics and Pharmacodynamics of Nicotine With Use of Standardized Research Electronic Cigarette (SREC)
RECRUITING · NA
-
Effects of Cannabidiol on Stress and Nicotine Withdrawal
RECRUITING · Phase 1
-
Overcoming Nicotine Dependence to Enable Quitting
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04353778 · 207 participants · Phase 1
Effects of Vagal Dysfunction on Gastrointestinal and Inflammatory Pathways in HIV
- NCT05875805 · 207 participants · NA
A Telehealth Advance Care Planning Intervention
- NCT06254950 · 207 participants · Phase 2
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Ulcerative Colitis
- NCT06904274 · 207 participants · Phase 3
Mirena for the Treatment of Nonatypical Endometrial Hyperplasia for 6 Months
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia